These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34184748)

  • 21. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB; Zhang WP; Shi JL; Wang JW
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
    Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
    Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis.
    Lei W; Huo Z
    Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors.
    Liang D; Wang HY; Fan S; Wang J; Shen Y; Gao CY; Wu ML; Lu SM; Zhang SQ; Han W
    Invest New Drugs; 2020 Oct; 38(5):1218-1226. PubMed ID: 31823159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
    Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.
    Bai X; He C; Fu B; Kong X; Bu J; Zhu K; Zheng W; Zhou F; Ni B
    Cell Cycle; 2020 Dec; 19(23):3260-3276. PubMed ID: 33222607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
    Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
    Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
    Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
    Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells.
    Liu X; Jiang Q; Liu H; Luo S
    Biol Res; 2019 Feb; 52(1):7. PubMed ID: 30797236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
    Han J; Hu J; Sun F; Bian H; Tang B; Fang X
    Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
    Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
    Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
    J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway.
    Li B; Yuan Z; Jiang J; Rao Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30420490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells.
    Wang J; Liu X; Zheng H; Liu Q; Zhang H; Wang X; Shen T; Wang S; Ren D
    Chem Biol Interact; 2020 Nov; 331():109279. PubMed ID: 33035517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling.
    Zhang C; Lan T; Hou J; Li J; Fang R; Yang Z; Zhang M; Liu J; Liu B
    Oncotarget; 2014 Jun; 5(12):4392-405. PubMed ID: 24946933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
    Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
    Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fungal Immunomodulatory Protein from
    Xie Y; Li S; Sun L; Liu S; Wang F; Wen B; Sun L; Fang X; Chai Y; Cao H; Jia N; Gu T; Lou X; Xin F
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.
    Li B; Wang Z; Zhong Y; Lan J; Li X; Lin H
    Med Oncol; 2015 Mar; 32(3):66. PubMed ID: 25691296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.